Search Results 41-50 of 7399 for ��������� ���������������������:zA33��������� ������ ������ ���������������������
Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
Zack Aibaidula, 2024 graduate of Mayo Clinic Graudate School of Biomedical Sciences, reflects on his journey from shepherd to neurosurgeon-scientist.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
The purpose of this study is to develop a large, well-characterized, biomarker-confirmed, trial-ready cohort to facilitate rapid enrollment into AD prevention ...
The primary purpose of this study is to determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ...
Mayo Clinic Research Core Facilities: Molecular development cores produce monoclonal and polyclonal antibodies and transgenic and knockout mice.
This is a Phase 2, multicenter, open-label study to evaluate the efficacy and safety of luspatercept in subjects with MPN-associated myelofibrosis and anemia ...
O. Orthopedic Biomechanics Research · Orthopedic Genetic Host Variation: Matthew P. Abdel · Osteoporosis and Bone Biology: Sundeep Khosla ...
B. B-Cell Lymphoproliferative Disorders: Susan L. Slager · Biliary Regenerative Medicine: Robert C. Huebert · Bioelectronics Neurophysiology and ...
The purpose of this trial is to identify the RP2D of STI-6129 by assessing the safety, preliminary effectiveness and pharmacokinetics in treating subjects with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.